Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 10/1/06 → 3/31/13 |
Financiación
- Tibotec Pharmaceuticals Ltd: 17.605,00 US$
A Phase II randomized, double-blinded, placebo controlled trial to investigate the efficacy, tolerability and safety of TMC 125 as part of
- Greenberg, Richard (PI)